Histogenics Corporation Forecast and Stock Analysis
Technical HSGX stock analysis for February 15, 2019.
Histogenics Corporation fell by -1.66% in the last day from $0.13 to $0.13 and has now fallen 3 days in a row. The price has been going up and down for this period, and there has been a -26.5% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1.19 million shares and in total 3.00 million shares bought and sold for approximately $389 950.00.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the HSGX stock was $0.13. This is 1.66% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 2.71% from a day low at $0.13 to a day high of $0.13.
30 day high of the HSGX stock price was $0.22 and low was $0.11.
90 day high was $0.59 and low was $0.08.
52 week high for the Histogenics Corporation - $3.35 and low - $0.08.
Histogenics Corporation lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -65.79% during the next 3 months and, with 90% probability hold a price between $-0.06 and $0.08 at the end of this period.
A buy signal was issued from a pivot bottom point on Friday February 08, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Histogenics Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.14 and $0.15. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 48 and the stock is currently not being overbought or oversold
Support & Resistance
Histogenics Corporation finds support from accumulated volume at $0.13.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 2.71%. For the last week the stock has had a daily average volatility of 7.84%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Histogenics Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.